Results round-up: Positive quarters for BD, HeartWare, Integra
This article was originally published in Clinica
Executive Summary
Becton Dickinson’s Q2 adjusted earnings of $1.53 per share grew 10% year-on-year and beat analyst predictions by $0.03. The firm was helped by “better profitability and a lower tax rate [that] more than offset slightly weaker revenue growth due to currency,” noted Jefferies analyst Brandon Couillard. The firm’s sales increased 4% year-on-year to $2.07bn, or 5% on a constant currency basis. However, its diagnostics division was “surprisingly weak,” with revenues down 1% (or +1% at constant exchange rates). This was offset by 5% and 8% growth in BD’s medical and biosciences units, respectively. Overall, the results “should inspire confidence in the prospects of a restoration of a double-digit growth trajectory in FY15, which should pique incremental investor attention,” concluded Mr Couillard. BD’s stock closed down 1% on 1 May, the day it reported the results, but its share price was up over 1% as Clinica went to press.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.